Incyte

FDA delays decision on Lilly and Incyte's arthritis drug
BioPharma Dive
Tue, 01/17/17 - 11:04 am
FDA
Eli Lilly
Incyte
rheumatoid arthritis
baricitinib
What Were Incyte’s Revenue Streams in 3Q16?
Market Realist
Sat, 01/7/17 - 12:38 pm
Incyte
Jakafi
Iclusig
Biotech Investing: 3 Bold Predictions for 2017
Motley Fool
Fri, 01/6/17 - 09:47 am
biotech
Incyte
Biogen
Biomarin
Gilead Sciences
Illumina
Biotech Stocks: What to Watch in 2017
Motley Fool
Tue, 01/3/17 - 10:02 am
biotech
M&A
drug launches
Gilead Sciences
Incyte
Spinraza
Biogen
Ionis Pharmaceuticals
Amgen
Regeneron
Sanofi
The Most Likely Incyte Acquisition Deal for 2017?
Motley Fool
Sat, 12/24/16 - 12:11 pm
M&A
Incyte
Gilead Sciences
Lilly
Novartis
Agenus
Incyte puts up $200M in bispecifics deal with Merus
BioPharma Dive
Thu, 12/22/16 - 10:21 am
Incyte
Merus
bispecific antibodies
Gilead Fails to Beat Incyte’s Jakafi Drug
Investopedia
Sat, 11/19/16 - 11:32 am
Gilead Sciences
Jakafi
Incyte
momelotinib
myelofibrosis
Should Gilead Sciences Purchase Incyte?
Seeking Alpha
Fri, 11/18/16 - 10:02 am
Gilead Sciences
Incyte
M&A
3 Biotechs Most Likely to Be Acquired
Motley Fool
Tue, 10/11/16 - 09:45 pm
biotech
M&A
Incyte
Biomarin
Biogen
Updated Incyte combo data for epacadostat/Keytruda look promising
Endpoints
Fri, 10/7/16 - 09:09 am
Incyte
epacadostat
Keytruda
Incyte Could Be A Takeover Target, Argus Lifts Price Target To $98
Yahoo/Benzinga
Tue, 09/27/16 - 10:04 pm
Incyte
M&A
After Losing Medivation, Who Is Gilead Going After Next?
Forbes
Mon, 09/19/16 - 03:39 pm
Medivation
Gilead Sciences
M&A
Puma Biotechnology
Kite Pharma
Incyte
Portola Pharmaceuticals
3 Biotech Stocks Could Be the Next Big Takeover Targets
24/7 Wall St
Wed, 08/31/16 - 09:20 am
biotech
M&A
Biomarin
Incyte
Tesaro
4 Biotech Buyout Targets for Gilead, Sanofi After Medivation Miss
Barron's
Tue, 08/23/16 - 11:11 am
biotech
M&A
Gilead Sciences
Sanofi
Medivation
Incyte
Biomarin
Tesaro
Seattle Genetics
3 Plausible Buyout Scenarios Within Biotech
Seeking Alpha
Tue, 07/5/16 - 10:20 am
biotech
Acadia
AstraZeneca
Allergan
Biogen
Teva Pharmaceutical
Biomarin
Incyte
Ironwood
Medivation
Pfizer
Relypsa
Synergy Pharmaceuticals
M&A
These 15 Biotech Companies Could Be Takeover Targets
Barron's
Wed, 06/29/16 - 12:56 pm
biotech
M&A
Alder Biopharmaceuticals
Biomarin
Coherus Biosciences
Intercept Pharma
Ultragenyx
Seattle Genetics
Adamas Pharmaceuticals
Alexion
Clovis Oncology
Corbus Pharmaceuticals
Incyte
Prothena
Puma Biotechnology
Tesaro
Versartis
FDA Grants Breakthrough Therapy Designation for Incyte’s Ruxolitinib (Jakafi®) in Acute Graft-Versus-Host Disease (GVHD)
Yahoo
Fri, 06/24/16 - 09:15 am
FDA
Incyte
Jakafi
breakthrough therapies
graft vs host disease
Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs
Yahoo
Thu, 06/9/16 - 10:10 am
baricitinib
Eli Lilly
Incyte
rheumatoid arthritis
Biotech: Is the Rally Real?
Barron's
Thu, 06/2/16 - 04:01 pm
biotech
Prothena
Biomarin
Vertex Pharmaceuticals
Incyte
Celgene
3 Big Battles Brewing in Biotech
Motley Fool
Sun, 04/10/16 - 01:50 pm
AstraZeneca
ZS-9
Relypsa
Veltassa
Synergy Pharmaceuticals
plecanatide
Linzess
Ironwood
Allergan
Incyte
Eli Lilly
baricitinib
AbbVie
Humira

Pages